Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Stussi

Showing results (11-20 of 19) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 19 results.
Bone Marrow Transplantation|July 20, 2002
Consequences of ABO incompatibility in allogeneic hematopoietic stem cell transplantationG Stussi, J Muntwyler, J R Passweg, et al.
Bone Marrow Transplantation|September 4, 2012
Allo-SCT for multiple myeloma in the era of novel agents: a retrospective study on behalf of Swiss Blood SCTS Gerull, M Stern, A Ben Aissa, et al.
Bone Marrow Transplantation|September 27, 2005
Transplant-associated microangiopathy (TAM) in recipients of allogeneic hematopoietic stem cell transplantsM T Martinez, Ch Bucher, G Stussi, et al.
Infection|July 6, 2010
Hemophagocytic syndrome caused by primary herpes simplex virus 1 infection: report of a first caseA Cusini, H F Günthard, G Stussi, et al.
Bone Marrow Transplantation|June 30, 2009
Double allogeneic hematopoietic SCT as a rescue therapy for poor-risk hematological malignanciesG Stussi, J Halter, A Tichelli, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|April 7, 2009
Changes of circulating antibody levels induced by ABO antibody adsorption for ABO-incompatible kidney transplantationP V Valli, G Puga Yung, T Fehr, et al.
Bone Marrow Transplantation|March 8, 2007
High-dose chemotherapy using BEAM without autologous rescue followed by reduced-intensity conditioning allogeneic stem-cell transplantation for refractory or relapsing lymphomas: a comparison of delayed versus immediate transplantationA S Buser, M Stern, C Bucher, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 2, 2013
Large genomic aberrations detected by SNP array are independent prognosticators of a shorter time to first treatment in chronic lymphocytic leukemia patients with normal FISHM Mian, A Rinaldi, A A Mensah, et al.
Bone Marrow Transplantation|September 17, 2013
The impact of T-cell depletion techniques on the outcome after haploidentical hematopoietic SCTA Marek, M Stern, Y Chalandon, et al.
Pageof 2

Showing results (11-20 of 19) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 19 results.
Bone Marrow Transplantation|July 20, 2002
Consequences of ABO incompatibility in allogeneic hematopoietic stem cell transplantationG Stussi, J Muntwyler, J R Passweg, et al.
Bone Marrow Transplantation|September 4, 2012
Allo-SCT for multiple myeloma in the era of novel agents: a retrospective study on behalf of Swiss Blood SCTS Gerull, M Stern, A Ben Aissa, et al.
Bone Marrow Transplantation|September 27, 2005
Transplant-associated microangiopathy (TAM) in recipients of allogeneic hematopoietic stem cell transplantsM T Martinez, Ch Bucher, G Stussi, et al.
Infection|July 6, 2010
Hemophagocytic syndrome caused by primary herpes simplex virus 1 infection: report of a first caseA Cusini, H F Günthard, G Stussi, et al.
Bone Marrow Transplantation|June 30, 2009
Double allogeneic hematopoietic SCT as a rescue therapy for poor-risk hematological malignanciesG Stussi, J Halter, A Tichelli, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|April 7, 2009
Changes of circulating antibody levels induced by ABO antibody adsorption for ABO-incompatible kidney transplantationP V Valli, G Puga Yung, T Fehr, et al.
Bone Marrow Transplantation|March 8, 2007
High-dose chemotherapy using BEAM without autologous rescue followed by reduced-intensity conditioning allogeneic stem-cell transplantation for refractory or relapsing lymphomas: a comparison of delayed versus immediate transplantationA S Buser, M Stern, C Bucher, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 2, 2013
Large genomic aberrations detected by SNP array are independent prognosticators of a shorter time to first treatment in chronic lymphocytic leukemia patients with normal FISHM Mian, A Rinaldi, A A Mensah, et al.
Bone Marrow Transplantation|September 17, 2013
The impact of T-cell depletion techniques on the outcome after haploidentical hematopoietic SCTA Marek, M Stern, Y Chalandon, et al.
Pageof 2